Prevalence of Interstitial Lung Disease in Patients with Primary Sjogren’s Syndrome: A Systematic Review and Meta-analysis of Observational Studies

Authors

  • Majid Molahoseini Isfahan University of Medical Science, Isfahan, Iran
  • Mansour Salesi Isfahan University of Medical Science, Isfahan, Iran

DOI:

https://doi.org/10.31661/gmj.v14i.3752

Keywords:

Primary Sjogren’s Syndrome; Primary Sicca Syndrome; Prevalence; Lung Diseases; Interstitial; Interstitial Lung Disease; Interstitial Pneumonia

Abstract

Background: Interstitial Lung Disease (ILD) is the most common pulmonary manifestation in patients with primary Sjögren’s syndrome. Therefore, this study aimed to investigate the prevalence of ILD in patients with primary Sjögren’s syndrome (pSS). Materials and Methods: This study searched databases ProQuest, PubMed, Web of Science, Cochrane, Embase, and the search engine Google Scholar until February 8, 2025. Studies were combined using the sample size and variance of each study. The heterogeneity of the studies was examined using the Q Cochrane test and the I2 index. . Results: 34 observational studies, with a total of 9535 individuals, showed that the prevalence of ILD in all patients with pSS was 23.5% (95%CI: 18.6%, 28.4%), in women 31.2% (95%CI: 18.4%, 44.1%), and in men 45.5% (95%CI: 23.6%, 67.4%). Moreover, the prevalence of ILD in patients with pSS in the age group of 30 to 39 years was 22.2% (95%CI: 18.9%, 26%), 40 to 49 years 10.8% (95%CI: 8.7%, 12.9%), 50 to 59 years 27.6% (95%CI: 17.9%, 37.4%), and 60 to 69 years 23.3% (95%CI: 17.9%, 28.7%). Also, the prevalence of ILD in patients with pSS in case-control studies was 15.6% (95%CI: 7.1%, 24.1%), in cohort studies 25.7% (95%CI: 19%, 32.4%), and in cross-sectional studies 21.4% (95%CI: 11.9%, 31%). However, the prevalence of non-specific interstitial pneumonia (NSIP) was 48.8% (95%CI: 41.4%, 56.2%), usual interstitial pneumonia (UIP) 15% (95%CI: 10.5%, 19.5%), LIP 10.8% (95%CI: 6.6%, 15%), and organizing pneumonia (OP) 9.4% (95%CI: 5.4%, 13.4%). Conclusion: One out of every four patients with pSS has ILD, and the prevalence of ILD was higher in men than in women. Moreover, the most common type of ILD was NSIP, followed by UIP, OP, and LIP, and the highest prevalence of ILD was in the age group of 50 to 59 years. 

References

Zhang N, Shi Q, Yao Q. Epidemiological studies on primary Sjogren's syndrome. Zhonghua Nei Ke Za Zhi. 1993 ; 32(8): 522-4.

Mariette X , Criswell L. Primary Sjögren's syndrome. N Engl J Med. 2018 Mar; 378(10): 931-9.

https://doi.org/10.1056/NEJMcp1702514

PMid:29514034

Tarn J, et al. Primary Sjögren's syndrome: Longitudinal real-world, observational data on health-related quality of life. J Intern Med. 2022; 291(6): 849-855.

https://doi.org/10.1111/joim.13451

PMid:35018685 PMCid:PMC9305875

Tsuboi H, et al. Primary and secondary surveys on epidemiology of Sjögren's syndrome in Japan. Mod Rheumatol. 2014 May; 24(3): 464-70.

https://doi.org/10.3109/14397595.2013.843765

PMid:24252039

Ansari N, Salesi M. The association between primary Sjogren's syndrome and non-Hodgkin's lymphoma: a systematic review and meta-analysis of cohort studies. Clin Rheumatol. 2024; 43(7): 2177-2186.

https://doi.org/10.1007/s10067-024-06993-6

PMid:38722505

Parambil J, et al. Interstitial lung disease in primary Sjögren syndrome. Chest. 2006; 130(5): 1489-95.

https://doi.org/10.1378/chest.130.5.1489

PMid:17099028

Fauchais A, et al. Immunological profile in primary Sjögren syndrome: clinical significance, prognosis and long-term evolution to other auto-immune disease. Autoimmun Rev. 2010 Jul; 9(9): 595-9.

https://doi.org/10.1016/j.autrev.2010.05.004

PMid:20457283

Gardiner P, et al. Pleuropulmonary abnormalities in primary Sjögren's syndrome. J Rheumatol. 1993; 20(5): 831-7.

Palm Ø, et al. Clinical pulmonary involvement in primary Sjögren's syndrome: prevalence, quality of life and mortality-a retrospective study based on registry data. Rheumatology (Oxford). 2013; 52(1): 173-9.

https://doi.org/10.1093/rheumatology/kes311

PMid:23192906

Luppi F, et al. Interstitial lung disease in Sjögren's syndrome: a clinical review. Clin Exp Rheumatol. 2020 ; 38: 291-300.

HaghighiKian SM, et al. A holistic approach to implementing artificial intelligence in lung cancer. Indian J Surg Oncol. 2025 Feb;16(1):257-78.

https://doi.org/10.1007/s13193-024-02079-6

PMid:40114896

Rezaeeyan H, Nobakht M Gh, Arabfard M. A computational approach for the identification of key genes and biological pathways of chronic lung diseases: a systems biology approach. BMC Med Genomics. 2023; 16(1): 159.

https://doi.org/10.1186/s12920-023-01596-7

PMid:37422662 PMCid:PMC10329352

Rezaeeyan H, et al. Evaluation of common protein biomarkers involved in the pathogenesis of respiratory diseases with proteomic methods: A systematic review. Immun Inflamm Dis. 2023; 11(11): e1090.

https://doi.org/10.1002/iid3.1090

PMid:38018577 PMCid:PMC10659759

Ahmadipour E, et al. Understanding kidney injury in COVID-19; a pressing priority. J Nephropharmacol. 2020; 10(2): e19-e19.

https://doi.org/10.34172/npj.2021.19

Dong X, et al. A retrospective analysis of distinguishing features of chest HRCT and clinical manifestation in primary Sjögren's syndrome-related interstitial lung disease in a Chinese population. Clin Rheumatol. 2018 Nov; 37(11): 2981-8.

https://doi.org/10.1007/s10067-018-4289-6

PMid:30242640

Roca F, et al. Interstitial lung disease in primary Sjögren's syndrome. Autoimmun Rev. 2017; 16(1): 48-54.

https://doi.org/10.1016/j.autrev.2016.09.017

PMid:27682894

Manfredi A, et al. Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement. Clin Rheumatol. 2017 Jun; 36(6): 1261-8.

https://doi.org/10.1007/s10067-017-3601-1

PMid:28324200

He C, et al. Prevalence and risk factors of interstitial lung disease in patients with primary Sjögren's syndrome: a systematic review and meta-analysis. Int J Rheum Dis. 2020 Aug; 23(8): 1009-18.

https://doi.org/10.1111/1756-185X.13881

PMid:32588976

Gao H, et al. Prevalence, risk factors, and prognosis of interstitial lung disease in a large cohort of Chinese primary Sjögren syndrome patients: a case-control study. Medicine. 2018; 97(24): e11003.

https://doi.org/10.1097/MD.0000000000011003

PMid:29901591 PMCid:PMC6023797

Kamiya Y, et al. Prognostic factors for primary Sjögren's syndrome-associated interstitial lung diseases. Respir Med. 2019 Nov; 159: 105811.

https://doi.org/10.1016/j.rmed.2019.105811

PMid:31710871

Moradi G, et al. Evaluating the Cavitary Lung Lesions on CT Scan of COVID-19 Patients: A Retrospective Study. J Community Hosp Intern Med Perspect. 2024; 14(6): 23.

https://doi.org/10.55729/2000-9666.1411

PMid:39839166 PMCid:PMC11745194

Cottin V, et al. Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases. Eur Respir Rev. 2018 Dec; 27(150): 180076.

https://doi.org/10.1183/16000617.0076-2018

PMid:30578335 PMCid:PMC9489068

Cottin V, et al. Fibrosing interstitial lung diseases: knowns and unknowns. Eur Respir Rev. 2019 Mar; 28(151): 180100.

https://doi.org/10.1183/16000617.0100-2018

PMid:30814139 PMCid:PMC9489101

Raji H, et al. Clinical, radiological outcomes and pulmonary function tests in patients recovered from COVID-19 in a three-month follow-up. Immunopathol Persa. 2024; 10(1): e31362.

https://doi.org/10.34172/ipp.2023.31362

Adereh A, et al. Loc646329 sponges miR-21 to reduce RAS/MAP kinase signaling pathway in oral squamous cell carcinoma (OSCC). Naunyn Schmiedebergs Arch Pharmacol. 2024; 398: 1-9.

https://doi.org/10.1007/s00210-024-03671-x

PMid:39673637

Ng K, et al. Risk of interstitial lung disease in patients with newly diagnosed systemic autoimmune rheumatic disease: a nationwide, population-based cohort study. Semin Arthritis Rheum. 2020 Oct; 50(5): 840-845.

https://doi.org/10.1016/j.semarthrit.2020.07.011

PMid:32896697

Moher D, et al. Preferred reporting items for systematic review and metaanalysis protocols (PRISMA-P) 2015 statement. Syst Rev J. 2015; 4: 1-9.

https://doi.org/10.1186/2046-4053-4-1

PMid:25554246 PMCid:PMC4320440

Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010; 25: 603-5.

https://doi.org/10.1007/s10654-010-9491-z

PMid:20652370

Manikuppam P, et al. Clinical Characteristics and Outcomes of Interstitial Lung Disease in Primary Sjögren's Syndrome: A Retrospective Cohort Study. Mediterr J Rheumatol. 2024 Mar; 35(1): 108-114.

https://doi.org/10.31138/mjr.230323.cca

PMid:38736967 PMCid:PMC11082778

Yang Z, et al. Clinical features and risk factors for primary Sjögren's syndrome combined with interstitial lung disease: a retrospective study. Acta Biochim Pol. 2024 Apr; 71: 12461.

https://doi.org/10.3389/abp.2024.12461

PMid:38721305 PMCid:PMC11077348

Wang Y, et al. Predicting the risk of interstitial lung disease in patients with primary Sjögren's syndrome: Novel nomogram and elevated Th2 cells. Mol Immunol. 2024 Apr;168: 25-37.

https://doi.org/10.1016/j.molimm.2024.02.008

PMid:38382243

Huang Y, et al. Risk factors and prognosis of interstitial lung disease for primary Sjögren syndrome patients: A retrospective case-control study. Clin Rheumatol. 2023 Nov; 42(11): 3033-41.

https://doi.org/10.1007/s10067-023-06596-7

PMid:37421537

Lee K, et al. Clinical course and risk factors for development and progression of interstitial lung disease in primary Sjögren's syndrome. Sci Rep. 2023 Jun; 13(1): 9189.

https://doi.org/10.1038/s41598-023-35608-4

PMid:37280251 PMCid:PMC10244322

He S, et al. Risk factors for progression of interstitial lung disease in Sjögren's syndrome: a single-centered, retrospective study. Clin Rheumatol. 2022 Apr; 41(4): 1153-1161.

https://doi.org/10.1007/s10067-021-05984-1

PMid:34757493

Lin W, et al. Interstitial lung disease in Primary Sjögren's syndrome . BMC Pulm Med. 2022 Feb; 22(1): 73.

https://doi.org/10.1186/s12890-022-01868-5

PMid:35220958 PMCid:PMC8882286

Işik Ö, Yazici A, Çefle A. The respiratory manifestations in patients with primary Sjögren s syndrome: is interstitial lung disease related to disease activity? Turk J Med Sci. 2022; 52(5): 1704-1712.

https://doi.org/10.55730/1300-0144.5513

PMid:36422505 PMCid:PMC10395710

Weng L, et al. Biomarkers of interstitial lung disease associated with primary Sjögren's syndrome. Eur J Med Res. 2022 Oct; 27(1): 199.

https://doi.org/10.1186/s40001-022-00828-3

PMid:36217184 PMCid:PMC9549683

Guo T, et al. Clinical profiles of SS-ILD compared with SS-NILD in a Chinese population: a retrospective analysis of 735 patients. Ann Med. 2021 Jan; 53(1): 1340-8.

https://doi.org/10.1080/07853890.2021.1965205

PMid:34402690 PMCid:PMC8382016

Zhang K, et al. The ratio of neutrophil to lymphocyte predicts interstitial lung disease and its prognosis in patients with primary Sjogren's syndrome: a retrospective analysis. Ann Palliat Med. 2021 Jun; 10(6): 6493501-6501.

https://doi.org/10.21037/apm-21-1043

PMid:34154345

Sahin Ozdemirel T, et al. The evaluation of lung involvement and functional capacities in patients diagnosed with primary Sjogren's syndrome. Int J Clin Pract. 2021 Oct; 75(10): e14635.

https://doi.org/10.1111/ijcp.14635

Yazisiz V, et al. Survival analysis of patients with Sjögren's syndrome in Turkey: a tertiary hospital-based study. Clin Rheumatol. 2020 Jan; 39(1): 233-41.

https://doi.org/10.1007/s10067-019-04744-6

PMid:31555987

Goules A, et al. Primary Sjögren's syndrome of early and late onset: distinct clinical phenotypes and lymphoma development. Front Immunol. 2020 Oct; 11: 594096.

https://doi.org/10.3389/fimmu.2020.594096

PMid:33193443 PMCid:PMC7604905

Zhao R, et al. Associated factors with interstitial lung disease and health-related quality of life in Chinese patients with primary Sjögren's syndrome. Clin Rheumatol. 2020 Feb; 39(2): 483-9.

https://doi.org/10.1007/s10067-019-04753-5

PMid:31578648

Heus A, et al. Pulmonary involvement in primary Sjögren's syndrome, as measured by the ESSDAI. Scand J Rheumatol. 2020 Jan; 49(1): 38-46.

https://doi.org/10.1080/03009742.2019.1634221

PMid:31556344

Sogkas G, et al. Lung Involvement in Primary Sjögren's Syndrome-An Under-Diagnosed Entity. Front Med (Lausanne). 2020 Jul; 7: 332.

https://doi.org/10.3389/fmed.2020.00332

PMid:32766261 PMCid:PMC7378373

Shi L, et al. Increases in tumor markers are associated with primary Sjögren's syndrome-associated interstitial lung disease. Ther Adv Chronic Dis. 2020 Jul; 11: 1-9.

https://doi.org/10.1177/2040622320944802

PMid:32843956 PMCid:PMC7418474

Guisado-Vasco P, et al. Quantitative assessment of interstitial lung disease in Sjögren's syndrome. PLoS One. 2019 Nov; 14(11): e0224772.

https://doi.org/10.1371/journal.pone.0224772

PMid:31703067 PMCid:PMC6839858

Wang Y, et al. Risk factors for primary Sjögren syndrome-associated interstitial lung disease. J Thorac Dis. 2018 Apr; 10(4): 2108-2117.

https://doi.org/10.21037/jtd.2018.03.120

PMid:29850114 PMCid:PMC5949459

Kakugawa T, et al. Lymphocytic focus score is positively related to airway and interstitial lung diseases in primary Sjögren's syndrome. Respir Med. 2018 Apr; 137: 95-102.

https://doi.org/10.1016/j.rmed.2018.02.023

PMid:29605220

Kampolis C, et al. Prevalence and spectrum of symptomatic pulmonary involvement in primary Sjögren's syndrome. Clin Exp Rheumatol. 2018 ;36(Suppl 112): 94-101.

Ramírez Sepúlveda J, et al. Long-term follow-up in primary Sjögren's syndrome reveals differences in clinical presentation between female and male patients. Biol Sex Differ. 2017; 8(1): 25.

https://doi.org/10.1186/s13293-017-0146-6

PMid:28789696 PMCid:PMC5549313

Ter Borg E, Kelder j. Development of new extra-glandular manifestations or associated auto-immune diseases after establishing the diagnosis of primary Sjögren's syndrome: A long-term study of the Antonius Nieuwegein Sjögren (ANS) cohort. Rheumatol Int. 2017 Jul; 37(7): 1153-1158.

https://doi.org/10.1007/s00296-017-3715-4

PMid:28424927

Li X, et al. Clinical and laboratory profiles of primary Sjogren's syndrome in a Chinese population: A retrospective analysis of 315 patients. Int J Rheum Dis. 2015; 18(4): 439-46.

https://doi.org/10.1111/1756-185X.12583

PMid:25925697

Kvarnström M, et al. Incident cases of primary Sjögren's syndrome during a 5-year period in Stockholm County: a descriptive study of the patients and their characteristics. Scand J Rheumatol. 2015 Mar; 44(2): 135-42.

https://doi.org/10.3109/03009742.2014.931457

PMid:25222653

Ter Borg E , Kelder j. Lower prevalence of extra-glandular manifestations and anti-SSB antibodies in patients with primary Sjögren's syndrome and widespread pain: evidence for a relatively benign subset. Clin Exp Rheumatol. 2014 May; 32(3): 349-53.

Nannini C, et al. Primary Sjögren's syndrome 1976-2005 and associated interstitial lung disease: a population-based study of incidence and mortality. BMJ Open. 2013 Nov; 3(11): e003569.

https://doi.org/10.1136/bmjopen-2013-003569

PMid:24282246 PMCid:PMC3845035

Lin D, et al. Clinical and prognostic characteristics of 573 cases of primary Sjögren's syndrome. Chin Med J (Engl). 2010; 123(22): 3252-7.

Papathanasiou M, et al. Reappraisal of respiratory abnormalities in primary and secondary Sjogren's syndrome: a controlled study. Chest. 1986 ; 90(3): 370-4.

https://doi.org/10.1378/chest.90.3.370

PMid:3743149

Constantopoulos S, Papadimitriou C, Moutsopoulos H. Respiratory manifestations in primary Sjögren's syndrome: a clinical, functional, and histologic study. Chest. 1985 Aug; 88(2): 226-9.

https://doi.org/10.1378/chest.88.2.226

PMid:4017677

Berardicurti O, et al. Interstitial lung disease and pulmonary damage in primary sjögren's syndrome: a systematic review and meta-analysis. J Clin Med. 2023 Mar; 12(7): 2586.

https://doi.org/10.3390/jcm12072586

PMid:37048669 PMCid:PMC10095380

Arbiv O, et al. Prevalence and Radiologic Patterns of Interstitial Lung Disease in Sjogren Syndrome: A Systematic Review and Meta-Analysis. Am J Respir Crit Care Med. 2022; 205: A2743.

https://doi.org/10.1164/ajrccm-conference.2022.205.1_MeetingAbstracts.A2743

Sambataro G, et al. Clinical, morphological features and prognostic factors associated with interstitial lung disease in primary Sjӧgren's syndrome: a systematic review from the Italian Society of Rheumatology. Autoimmun Rev. 2020 Feb; 19(2): 102447.

https://doi.org/10.1016/j.autrev.2019.102447

PMid:31843713

Joy G, et al. Prevalence, imaging patterns and risk factors of interstitial lung disease in connective tissue disease: a systematic review and meta-analysis. Eur Respir Rev. 2023 Mar; 32(167): 220210.

https://doi.org/10.1183/16000617.0210-2022

PMid:36889782 PMCid:PMC10032591

Downloads

Published

2025-10-20

How to Cite

Molahoseini, M., & Salesi, M. (2025). Prevalence of Interstitial Lung Disease in Patients with Primary Sjogren’s Syndrome: A Systematic Review and Meta-analysis of Observational Studies. Galen Medical Journal, 14, e3752. https://doi.org/10.31661/gmj.v14i.3752

Issue

Section

Review Article